HuGE Literature Finder
Records
1
-
22
| Single Nucleotide Polymorphisms in Selected Genes in Inflammatory Bowel Disease. BioMed research international 2018 2018 6914346. Dudzi?ska Ewa, Gryzinska Magdalena, Kocki Janu |
| Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel disease. Scientific reports 2016 6 33550. Li Yunhai, Chen Ping, Sun Jiazheng, Huang Jing, Tie Hongtao, Li Liangliang, Li Hongzhong, Ren Guoshe |
| NOD2 mutations affect muramyl dipeptide stimulation of human B lymphocytes and interact with other IBD-associated genes. Digestive diseases and sciences 2013 Sep 58 (9): 2599-607. Lin Zhenwu, Hegarty John P, John Gerrit, Berg Arthur, Wang Zhong, Sehgal Rishabh, Pastor Danielle M, Wang Yunhua, Harris Leonard R, Poritz Lisa S, Schreiber Stefan, Koltun Walter |
| DLG5 P1371Q is associated with inflammatory bowel disease and complementary to R30Q in disease susceptibility. Swiss medical weekly 2011 141 w13290. Lin Zhenwu, Hegarty John P, Berb Arthur, Wang Zhong, Kelly Ashley A, Wang Yunhua, Poritz Lisa S, Wu Rongling, Koltun Walter |
| Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease. The American journal of gastroenterology 2009 Jul 104 (7): 1723-33. Török Helga P, Glas Jürgen, Endres Ilona, Tonenchi Laurian, Teshome Molla Y, Wetzke Martin, Klein Wolfram, Lohse Peter, Ochsenkühn Thomas, Folwaczny Matthias, Göke Burkhard, Folwaczny Christian, Müller-Myhsok Bertram, Brand Steph |
| Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort. Gut 2009 Mar 58 (3): 388-95. Weersma R K, Stokkers P C F, van Bodegraven A A, van Hogezand R A, Verspaget H W, de Jong D J, van der Woude C J, Oldenburg B, Linskens R K, Festen E A M, van der Steege G, Hommes D W, Crusius J B A, Wijmenga C, Nolte I M, Dijkstra G, |
| Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population. Inflammatory bowel diseases 2008 Aug 14 (8): 1118-24. Lappalainen Maarit, Halme Leena, Turunen Ulla, Saavalainen Päivi, Einarsdottir Elisabet, Färkkilä Martti, Kontula Kimmo, Paavola-Sakki Pauli |
| Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients. BMC medical genetics 2008 9 (1): 81. Gaj Pawel, Habior Andrzej, Mikula Michal, Ostrowski Jer |
| Association of DLG5 variants with inflammatory bowel disease in the New Zealand Caucasian population and meta-analysis of the DLG5 R30Q variant. Inflammatory bowel diseases 2007 Sep 13 (9): 1069-76. Browning Brian L, Huebner Claudia, Petermann Ivonne, Demmers Pieter, McCulloch Alan, Gearry Richard B, Barclay Murray L, Shelling Andrew N, Ferguson Lynnette |
| Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases. World journal of gastroenterology : WJG 2007 Feb 13 (8): 1221-9. Cucchiara S, Latiano A, Palmieri O, Staiano A M, D'Incà R, Guariso G, Vieni G, Rutigliano V, Borrelli O, Valvano M R, Annese |
| Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. The American journal of gastroenterology 2007 Jan 102 (1): 115-21. Karlsen Tom H, Hampe Jochen, Wiencke Kristine, Schrumpf Erik, Thorsby Erik, Lie Benedicte A, Broomé Ulrika, Schreiber Stefan, Boberg Kirsten Mu |
| DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease. Inflammatory bowel diseases 2006 May 12 (5): 362-8. Lakatos Peter Laszlo, Fischer Simon, Claes Karolien, Kovacs Agota, Molnar Tamas, Altorjay Istvan, Demeter Pal, Tulassay Zsolt, Palatka Karoly, Papp Maria, Rutgeerts Paul, Szalay Ferenc, Papp Janos, Vermeire Severine, Lakatos Laszlo, |
| Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study. Inflammatory bowel diseases 2006 May 12 (5): 355-61. Ferraris Alessandro, Torres Barbara, Knafelz Daniela, Barabino Arrigo, Lionetti Paolo, de Angelis Gian Luigi, Iacono Giuseppe, Papadatou Bronislava, D'Amato Giovanna, Di Ciommo Vincenzo, Dallapiccola Bruno, Castro Massi |
| DLG5 variants contribute to Crohn disease risk in a Canadian population. Human mutation 2006 Apr 27 (4): 353-8. Newman William G, Gu Xiangjun, Wintle Richard F, Liu Xiangdong, van Oene Mark, Amos Christopher I, Siminovitch Katherine |
| DLG5 variants in inflammatory bowel disease. The American journal of gastroenterology 2006 Apr 101 (4): 786-92. Büning Carsten, Geerdts Lars, Fiedler Thomas, Gentz Enno, Pitre Ghyslaine, Reuter Wolf, Luck Werner, Buhner Sabine, Molnar Tomas, Nagy Ferenc, Lonovics Janos, Dignass Axel, Landt Olfert, Nickel Renate, Genschel Janine, Lochs Herbert, Schmidt Hartmut H-J, Witt Hei |
| Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations. European journal of human genetics : EJHG 2006 Apr 14 (4): 459-68. Medici Valentina, Mascheretti Silvia, Croucher Peter J P, Stoll Monika, Hampe Jochen, Grebe Jochen, Sturniolo Giacomo C, Solberg Camilla, Jahnsen Jorgen, Moum Bjorn, Schreiber Stefan, Vatn Morten |
| Genetic variants in TNF-alpha but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort. Inflammatory bowel diseases 2006 Mar 12 (3): 178-84. Tremelling Mark, Waller Sarah, Bredin Francesca, Greenfield Simon, Parkes Mil |
| Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD. Gastroenterology 2005 Dec 129 (6): 1845-53. Vermeire Séverine, Pierik Marie, Hlavaty Tibor, Claessens Greet, van Schuerbeeck Nele, Joossens Sofie, Ferrante Marc, Henckaerts Liesbet, Bueno de Mesquita Mirjam, Vlietinck Robert, Rutgeerts Pa |
| DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population. Gut 2005 Oct 54 (10): 1416-20. Noble C L, Nimmo E R, Drummond H, Smith L, Arnott I D R, Satsangi |
| Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut 2005 Oct 54 (10): 1421-7. Török H-P, Glas J, Tonenchi L, Lohse P, Müller-Myhsok B, Limbersky O, Neugebauer C, Schnitzler F, Seiderer J, Tillack C, Brand S, Brünnler G, Jagiello P, Epplen J T, Griga T, Klein W, Schiemann U, Folwaczny M, Ochsenkühn T, Folwaczny |
| Association of DLG5 R30Q variant with inflammatory bowel disease. European journal of human genetics : EJHG 2005 Jul 13 (7): 835-9. Daly Mark J, Pearce Alexandra V, Farwell Lisa, Fisher Sheila A, Latiano Anna, Prescott Natalie J, Forbes Alastair, Mansfield John, Sanderson Jeremy, Langelier Diane, Cohen Albert, Bitton Alain, Wild Gary, Lewis Cathryn M, Annese Vito, Mathew Christopher G, Rioux John |
| Genetic variation in DLG5 is associated with inflammatory bowel disease. Nature genetics 2004 May 36 (5): 476-80. Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, Koch WA, Rosenstiel P, Albrecht M, Croucher PJ, Seegert D, Nikolaus S, Hampe J, Lengauer T, Pierrou S, Foelsch UR, Mathew CG, Lagerstrom-Fermer M, Schreiber S |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 30, 2023
- Content source: